Act Now or Lose Your Chance: GERN Investors Have 60 Days to Lead a $100K+ Fraud Lawsuit

The clock is ticking for investors in Geron Corporation (NASDAQ: GERN) who lost over $100,000 during the company’s recent stock crash. If you’re one of them, this is your moment to take charge—or risk losing your seat at the table forever. Let me break down what you need to know to protect your money and hold GERN accountable.

What Happened to GERN?

Geron’s troubles began with its drug RYTELO (imetelstat), marketed as a breakthrough treatment for chronic anemia. Between February 2024 and February 2025, the company hyped RYTELO’s “transformational” potential, claiming it would dominate a “significant unmet need” in the market. But behind the scenes, GERN allegedly downplayed critical risks:

• Seasonality issues: Sales stalled in winter months due to lower patient visits.
• Lack of provider awareness: Doctors weren’t prescribing RYTELO because they didn’t know about it.
• Competitors in the wings: Roche’s Mircera and Amgen’s Aranesp were undercutting RYTELO’s appeal.

Then, on February 26, 2025, the truth hit like a ton of bricks. GERN admitted RYTELO’s growth had “flattened,” and its stock tanked 32% in a single day, from $2.37 to $1.61. Investors who bought in during the hype got crushed—and now they’re fighting back.

Your Deadline: May 12, 2025

Here’s why this is urgent:

• $100K+ losses? You can lead the lawsuit. If your GERN losses during the Class Period (Feb 28, 2024, to Feb 25, 2025) exceed $100,000, you’re eligible to be the lead plaintiff. That means you’ll pick the lawyers and steer the case. But you’ve got to act fast—the court’s deadline is May 12, 2025.

• Lower losses? Still get a cut. Even investors with losses below $100K can join the class action. But you’ll need to file a claim by the same deadline to ensure you’re part of any settlement.

Why This Matters: The Stock’s Free Fall (And Your Recovery)

Take a look at GERN’s stock since the scandal:

This isn’t just a blip—it’s a catastrophic drop fueled by corporate lies. The lawsuits allege GERN executives knew about RYTELO’s flaws but kept quiet to keep the stock artificially high. If the plaintiffs win, you could recover some of your losses. But only if you act now.

The Lawyers You Need—and Why They Matter

Multiple top firms are fighting for your rights:

1. Faruqi & Faruqi: They explicitly target investors with $100K+ losses, citing GERN’s “egregious misstatements.” Their track record? Over $1.2 billion recovered in securities cases last year alone.
2. Kessler Topaz: A global powerhouse with expertise in biotech fraud cases. They’ve won landmark settlements, including a $1.5 billion verdict against a drug company in 2023.
3. The Gross Law Firm: Focuses on holding corporations accountable, with a recent $450 million win for investors in a tech fraud case.

The Bottom Line: Don’t Sit This Out

Here’s the math: If you held GERN during the Class Period and lost big, you’ve got 60 days to seize control of this case. The lead plaintiff picks the lawyers, negotiates with GERN, and ensures the case isn’t settled for peanuts. But if you wait too long, someone else will do it—and you’ll have no say.

This is your moment to fight back. Contact a law firm today, file your claim, and make sure GERN pays for its lies.

Final Call to Action:

• Deadline: May 12, 2025—no exceptions.
• Firms to contact: Faruqi & Faruqi (faruqilaw.com/GERN), Kessler Topaz (ktmc.com/geron), or The Gross Law Firm (securitiesclasslaw.com/geron).
• Remember: No upfront fees. They work on contingency—meaning they only get paid if you win.

The clock’s ticking. Don’t let this chance slip away.

Conclusion: GERN’s stock crash was no accident—it was fueled by lies that cost investors millions. The legal system is your weapon to claw back losses, but only if you move fast. With a 32% plunge on a single day and top law firms ready to fight, this is a rare opportunity to hold corporate wrongdoers accountable. Act now, or regret it forever. The ball is in your court—what will you do?